Jove
Visualize
Contact Us

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

478
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
478
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

113
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
113
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

112
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
112

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum IFABP level as an index of mucosal health in celiac disease: a small intestinal morphometry study.

Clinical and translational gastroenterology·2026
Same author

The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint-gut remission: Four-year outcomes from the real-world SPIB cohort.

Seminars in arthritis and rheumatism·2026
Same author

Lifestyle intervention to reduce cardiovascular risk in kidney transplant recipients: the KT-LIFESTYLE multicentre randomized controlled trial.

Clinical kidney journal·2026
Same author

Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in <i>BRAF</i>-Mutant Melanoma.

bioRxiv : the preprint server for biology·2026
Same author

Expanding P-NET, a multi-purpose biologically informed deep learning framework.

bioRxiv : the preprint server for biology·2026
Same author

Medical clinical minds meet artificial intelligence: Italian physicians' knowledge, attitudes, and concordance between Italian physicians and AI-generated diagnoses. A national cross-sectional study.

Frontiers in digital health·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 16, 2025

Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

6.9K

Risk Stratification in Primary Biliary Cholangitis.

Francesco Martini1, Daniele Balducci1, Martina Mancinelli1

  • 1Clinic of Gastroenterology, Hepatology, and Emergency Digestive Endoscopy, Università Politecnica delle Marche, 60126 Ancona, Italy.

Journal of Clinical Medicine
|September 9, 2023
PubMed
Summary

Primary Biliary Cholangitis (PBC) risk stratification is evolving. New models will personalize treatment by predicting disease progression and therapy response at diagnosis.

Keywords:
precision medicineprimary biliary cholangitisrisk stratification

More Related Videos

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts
09:55

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Published on: May 16, 2020

3.9K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.5K

Related Experiment Videos

Last Updated: Jul 16, 2025

Determining Bile Duct Density in the Mouse Liver
07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

6.9K
Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts
09:55

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Published on: May 16, 2020

3.9K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.5K

Area of Science:

  • Hepatology
  • Internal Medicine
  • Clinical Research

Background:

  • Primary Biliary Cholangitis (PBC) is a chronic liver disease with variable patient outcomes.
  • Current risk assessment relies on demographic, clinical, laboratory, and fibrosis data.
  • Treatment response after one year is a key prognostic factor.

Purpose of the Study:

  • To review current and emerging tools for risk stratification in PBC.
  • To discuss the potential for personalized treatment strategies in PBC.
  • To highlight the need for predictive models for PBC diagnosis and treatment.

Main Methods:

  • Review of existing literature on PBC risk stratification.
  • Analysis of demographic, clinical, laboratory, and fibrosis assessment tools.
  • Discussion of treatment response scores and emerging therapies.

Main Results:

  • Risk stratification integrates diverse patient data, including fibrosis.
  • Treatment response to ursodeoxycholic acid (UDCA) and second-line therapies influences prognosis.
  • A shift towards personalized medicine is anticipated.

Conclusions:

  • Risk stratification in PBC is becoming more sophisticated.
  • Personalized treatment strategies will likely replace the current one-size-fits-all approach.
  • Development of predictive models is crucial for optimizing PBC patient care.